Log in to save to my catalogue

Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients

Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e25e88ea2d44a43a3b0e4d1a6c5df91

Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients

About this item

Full title

Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients

Publisher

London: Nature Publishing Group UK

Journal title

Blood cancer journal (New York), 2023-05, Vol.13 (1), p.68-68, Article 68

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Most patients with multiple myeloma (MM) undergoing autologous hematopoietic stem cell transplantation (autoHCT) eventually relapse, perhaps due to the presence of clonal plasma cells (CPC) in the autograft. We conducted a retrospective analysis to evaluate the impact of CPC in the autograft on the outcomes of high-risk chromosomal abnormalities (H...

Alternative Titles

Full title

Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4e25e88ea2d44a43a3b0e4d1a6c5df91

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4e25e88ea2d44a43a3b0e4d1a6c5df91

Other Identifiers

ISSN

2044-5385

E-ISSN

2044-5385

DOI

10.1038/s41408-023-00842-6

How to access this item